Antimicrobial Resistance and Its Spread Is a Global Threat
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Antimicrobial resistance (AMR) is a challenge to human wellbeing the world over and is one of the more serious public health concerns. AMR has the potential to emerge as a serious healthcare threat if left unchecked, and could put into motion another pandemic. This establishes the need for the establishment of global health solutions around AMR, taking into account microdata from different parts of the world. The positive influences in this regard could be establishing conducive social norms, charting individual and group behavior practices that favor global human health, and lastly, increasing collective awareness around the need for such action. Apart from being an emerging threat in the clinical space, AMR also increases treatment complexity, posing a real challenge to the existing guidelines around the management of antibiotic resistance. The attribute of resistance development has been linked to many genetic elements, some of which have complex transmission pathways between microbes. Beyond this, new mechanisms underlying the development of AMR are being discovered, making this field an important aspect of medical microbiology. Apart from the genetic aspects of AMR, other practices, including misdiagnosis, exposure to broad-spectrum antibiotics, and lack of rapid diagnosis, add to the creation of resistance. However, upgrades and innovations in DNA sequencing technologies with bioinformatics have revolutionized the diagnostic industry, aiding the real-time detection of causes of AMR and its elements, which are important to delineating control and prevention approaches to fight the threat.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial Resistance: Implications and Costs
Dadgostar, P. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s234610 · Cited by 2,024 · cited 1×
“Conditions which necessitate the use of “last-resort” antibiotics also significantly increase treatment costs to the client, prolonging in-hospital time and admission rates [16,17].”
BackgroundMapping human microbiome drug metabolism by gut bacteria and their genes
Zimmermann, M., Zimmermann-Kogadeeva, M., Wegmann, R., & Goodman, A. L. (2019) · Nature · doi:10.1038/s41586-019-1291-3 · Cited by 1,160
Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme
Wallace, B. D., Wang, H., Lane, K. T., Scott, J. E., Orans, J., Koo, J. S., Venkatesh, M., Jobin, C., Yeh, L.-A., Mani, S., et al. (2010) · Science · doi:10.1126/science.1191175 · Cited by 1,080
Effects of antibiotics on gut microbiota
Lange, K., Buerger, M., Stallmach, A., & Bruns, T. (2016) · Digestive Diseases · doi:10.1159/000443360 · Cited by 607 · cited 1×
“Apart from AMR, studies have also implicated impacts of antibiotics on diseases, including obesity, cancer, and inflammatory bowel disease [23].”
BackgroundAntibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans
Hagan, T., Cortese, M., Rouphael, N., Boudreau, C., Linde, C., Maddur, M. S., Das, J., Wang, H., Guthmiller, J., Zheng, N.-Y., et al. (2019) · Cell · doi:10.1016/j.cell.2019.08.010 · Cited by 572 · cited 1×
“Analysis found enhanced inflammatory signatures and a reduction in bile acids causing inflammasome activation [28].”
BackgroundZarrinpar, A., Chaix, A., Xu, Z. Z., Chang, M. W., Marotz, C. A., Saghatelian, A., Knight, R., & Panda, S. (2018) · Nature Communications · doi:10.1038/s41467-018-05336-9 · Cited by 546 · cited 1×
“Antibiotic-induced microbiome depletion is a well-documented phenomenon due to antibiotic therapy and has been implicated in the alteration of metabolic homeostasis through gut signaling [26].”
BackgroundAlexander Fleming (1881–1955): Discoverer of penicillin
Tan, S., & Tatsumura, Y. (2015) · Singapore Medical Journal · doi:10.11622/smedj.2015105 · Cited by 342
Kent, A. G., Vill, A. C., Shi, Q., Satlin, M. J., & Brito, I. L. (2020) · Nature Communications · doi:10.1038/s41467-020-18164-7 · Cited by 216 · cited 1×
“Studies have documented gut microbiota to be a rich reserve of antibiotic resistance (AR) which contributes to the emergence of multidrug resistance by horizontal gene transfer (HGT), which is also triggered during use of antibiotics as vital prophylaxis [25].”
BackgroundPerspectives for clinical use of engineered human host defense antimicrobial peptides
Pachón-Ibáñez, M. E., Smani, Y., Pachón, J., & Sánchez-Céspedes, J. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux012 · Cited by 159
Spichak, S., Bastiaanssen, T. F. S., Berding, K., Vlckova, K., Clarke, G., Dinan, T. G., & Cryan, J. F. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.044 · Cited by 127
Cited by
An Overview of the Recent Advances in Antimicrobial Resistance
Oliveira, M., Antunes, W., Mota, S., Madureira-Carvalho, Á., Dinis-Oliveira, R. J., & Dias da Silva, D. (2024) · Microorganisms · doi:10.3390/microorganisms12091920 · Cited by 285
Using Machine Learning to Predict Antimicrobial Resistance―A Literature Review
Sakagianni, A., Koufopoulou, C., Feretzakis, G., Kalles, D., Verykios, V. S., Myrianthefs, P., & Fildisis, G. (2023) · Antibiotics · doi:10.3390/antibiotics12030452 · Cited by 176
“With increasing antibiotic consumption, resistance patterns can change over time, requiring periodic retraining [4].”
BackgroundInfluential
Metadata
- Authors
- Aljeldah, M. M.
- Venue
- Antibiotics
- Publisher
- MDPI AG
- Published
- 2022-08-09
- Volume
- 11
- Issue
- 8
- Pages
- 1082
- ISSN
- 2079-6382 (ISSN-L)
- OpenAlex
- W4292466728
- Cited by
- 247
- References
- 10
- FWCI
- 19.12
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.